92 related articles for article (PubMed ID: 36354990)
21. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.
Yoo SY; Badrinath N; Woo HY; Heo J
Mediators Inflamm; 2017; 2017():5198798. PubMed ID: 28512387
[TBL] [Abstract][Full Text] [Related]
22. Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma.
Jebar AH; Errington-Mais F; Vile RG; Selby PJ; Melcher AA; Griffin S
J Gen Virol; 2015 Jul; 96(Pt 7):1533-50. PubMed ID: 25711964
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic Vaccinia Virus Carrying
Zheng X; Xu W; Ying Q; Ni J; Jia X; Zhou Y; Ye T; Li G; Chen K
Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354990
[No Abstract] [Full Text] [Related]
24. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
[TBL] [Abstract][Full Text] [Related]
25. Oncolytic Vaccinia Virus Expressing
Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
[TBL] [Abstract][Full Text] [Related]
26. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells.
Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
[TBL] [Abstract][Full Text] [Related]
27. Oncolytic Vaccinia Virus Harboring
Jiang R; Qiu Y; Zhang X; Zhou N; Jia X; Chen K; Zhou Y; Ye T; Li G
Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736181
[TBL] [Abstract][Full Text] [Related]
28. Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation.
Bhosale PB; Kim HH; Abusaliya A; Vetrivel P; Ha SE; Park MY; Lee HJ; Kim GS
Evid Based Complement Alternat Med; 2022; 2022():9797929. PubMed ID: 35664945
[TBL] [Abstract][Full Text] [Related]
29. Oncolytic Vaccinia Virus in Lung Cancer Vaccines.
Truong CS; Yoo SY
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214699
[TBL] [Abstract][Full Text] [Related]
30. Oncolytic Vaccinia Virus Harboring
Ni J; Feng H; Xu X; Liu T; Ye T; Chen K; Li G
Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677432
[No Abstract] [Full Text] [Related]
31. Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation.
Sugawara K; Iwai M; Ito H; Tanaka M; Seto Y; Todo T
Mol Ther Oncolytics; 2021 Sep; 22():129-142. PubMed ID: 34514094
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial.
Zhang B; Huang J; Tang J; Hu S; Luo S; Luo Z; Zhou F; Tan S; Ying J; Chang Q; Zhang R; Geng C; Wu D; Gu X; Liu B
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33837053
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
